Mackenzie Financial’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.51M | Sell |
25,985
-64,146
| -71% | -$6.58M | ﹤0.01% | 873 |
|
|
2025
Q4 | $9.69M | Sell |
90,131
-86,376
| -49% | -$10M | 0.01% | 510 |
|
|
2025
Q3 | $22.4M | Buy |
176,507
+402
| +0.2% | +$47.9K | 0.03% | 360 |
|
|
2025
Q2 | $21.6M | Buy |
176,105
+153,594
| +682% | +$17.5M | 0.03% | 352 |
|
|
2025
Q1 | $2.28M | Sell |
22,511
-15,791
| -41% | -$1.54M | ﹤0.01% | 745 |
|
|
2024
Q4 | $3.54M | Sell |
38,302
-12,437
| -25% | -$1.22M | ﹤0.01% | 638 |
|
|
2024
Q3 | $4.9M | Sell |
50,739
-13,476
| -21% | -$1.21M | 0.01% | 547 |
|
|
2024
Q2 | $5.51M | Sell |
64,215
-13,079
| -17% | -$1.1M | 0.01% | 525 |
|
|
2024
Q1 | $6.38M | Sell |
77,294
-53
| -0.1% | -$3.88K | 0.01% | 516 |
|
|
2023
Q4 | $5.16M | Buy |
77,347
+40,739
| +111% | +$2.64M | 0.01% | 547 |
|
|
2023
Q3 | $2.41M | Sell |
36,608
-34,799
| -49% | -$2.39M | ﹤0.01% | 676 |
|
|
2023
Q2 | $4.79M | Buy |
71,407
+32,337
| +83% | +$2.03M | 0.01% | 556 |
|
|
2023
Q1 | $2.11M | Buy |
39,070
+11,131
| +40% | +$648K | ﹤0.01% | 727 |
|
|
2022
Q4 | $1.67M | Buy |
27,939
+20,396
| +270% | +$1.11M | ﹤0.01% | 714 |
|
|
2022
Q3 | $341K | Sell |
7,543
-605
| -7% | -$30.3K | ﹤0.01% | 1044 |
|
|
2022
Q2 | $289K | Buy |
+8,148
| New | +$418K | ﹤0.01% | 1108 |
|
|
2022
Q1 | – | Sell |
-16,080
| Closed | -$835K | – | 1436 |
|
|
2021
Q4 | $835K | Sell |
16,080
-5,633
| -26% | -$291K | ﹤0.01% | 938 |
|
|
2021
Q3 | $1.3M | Buy |
+21,713
| New | +$1.37M | ﹤0.01% | 860 |
|
|
2021
Q2 | – | Sell |
-3,782
| Closed | -$252K | – | 1247 |
|
|
2021
Q1 | $246K | Buy |
3,782
+342
| +10% | +$22.3K | ﹤0.01% | 1049 |
|
|
2020
Q4 | $226K | Buy |
+3,440
| New | +$202K | ﹤0.01% | 982 |
|
|
2019
Q2 | – | Sell |
-28,930
| Closed | -$1.34M | – | 1135 |
|
|
2019
Q1 | $1.34M | Buy |
28,930
+6,836
| +31% | +$346K | ﹤0.01% | 869 |
|
|
2018
Q4 | $1.08M | Buy |
22,094
+18,496
| +514% | +$1.05M | ﹤0.01% | 798 |
|
|
2018
Q3 | $223K | Buy |
+3,598
| New | +$219K | ﹤0.01% | 1050 |
|
|
2016
Q3 | – | Sell |
-28,085
| Closed | -$867K | – | 713 |
|
|
2016
Q2 | $867K | Sell |
28,085
-18,801
| -40% | -$588K | ﹤0.01% | 631 |
|
|
2016
Q1 | $1.4M | Hold |
46,886
| – | – | 0.01% | 425 |
|
|
2015
Q4 | $1.3M | Buy |
46,886
+16,467
| +54% | +$468K | 0.01% | 490 |
|
|
2015
Q3 | $929K | Buy |
+30,419
| New | +$1.06M | 0.01% | 552 |
|
Other funds holding EHC
VPM
VCM
Mackenzie Financial's EHC Position: Q1 2026 in Review
Mackenzie Financial reduced its Encompass Health (EHC) stake by 71% in Q1 2026, selling an estimated $6.58M and leaving 25,985 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #873.
Mackenzie Financial first reported a position in EHC in Q3 2015 and has held it in 27 quarters since. The position peaked at $22.4M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Mackenzie Financial held 25,985 shares of Encompass Health worth $2.51M as of Q1 2026.
- Mackenzie Financial sold 64,146 Encompass Health shares in Q1 2026, an estimated $6.58M.
- Encompass Health made up ﹤0.01% of Mackenzie Financial's portfolio in Q1 2026, its #873 holding.
- Mackenzie Financial first reported a position in Encompass Health in Q3 2015 and has held it in 27 quarters since.
- Mackenzie Financial's Encompass Health position peaked at $22.4M in Q3 2025.
- 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.